18. Vanhoorelbeke K, Depraetere H, Romijn RA, Huizinga EG, De Maeyer M, et al. (2003) A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction. J Biol Chem 278: 37815–37821. 19. Lecut C, Arocas V, Ulrichts H, Elbaz A, Villeval JL, et al. (2004) Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites. J Biol Chem 279: 52293–52299. 20. Nelson TJ, Alkon DL (2007) Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid. J Biol Chem 282: 31238–31249. 21. Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, et al. (2007) From combinatorial chemistry to cancer-targeting peptides. Mol Pharm 4: 631–651. 22. Gawaz M, Konrad I, Hauser AI, Sauer S, Li Z, et al. (2005) Non-invasive imaging of glycoprotein VI binding to injured arterial lesions. Thromb Haemost 93: 910–913. 23. Massberg S, Konrad I, Bultmann A, Schulz C, Munch G, et al. (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. Faseb J 18: 397–399. 24. Depraetere H, Viaene A, Deroo S, Vauterin S, Deckmyn H (1998) Identification of peptides, selected by phage display technology, that inhibit von Willebrand factor binding to collagen. Blood 92: 4207–4211. 25. Viaene A, Crab A, Meiring M, Pritchard D, Deckmyn H (2001) Identification of a collagen-binding protein from Necator americanus by using a cDNA- expression phage display library. J Parasitol 87: 619–625. Molecular Imaging of Fibrosis 26. Krahn KN, Bouten CV, van Tuijl S, van Zandvoort MA, Merkx M (2006) Fluorescently labeled collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. Anal Biochem 350: 177–185. 27. Megens RT, Oude Egbrink MG, Cleutjens JP, Kuijpers MJ, Schiffers PH, et al. (2007) Imaging collagen in intact viable healthy and atherosclerotic arteries using fluorescently labeled CNA35 and two-photon laser scanning microscopy. Mol Imaging 6: 247–260. 28. Helm PA, Caravan P, French BA, Jacques V, Shen L, et al. (2008) Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen- targeting contrast agent. Radiology 247: 788–796. 29. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, et al. (2008) Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117: 379–387. 30. Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90: 57–70. 31. Petegnief Y, Petiet A, Peker MC, Bonnin F, Meulemans A, et al. (1998) Quantitative autoradiography using a radioimager based on a multiwire proportional chamber. Phys Med Biol 43: 3629–3638. 32. Fabre A, Marchal-Somme J, Marchand-Adam S, Quesnel C, Borie R, et al. (2008) Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice. Eur Respir J 32: 426–436. PLoS ONE | www.plosone.org 10 May 2009 | Volume 4 | Issue 5 | e5585